MULTICENTER STUDY ON THE

NATURAL HISTORY OF CHIKUNGUNYA AND THERAPEUTIC RESPONSE

Main project with focus on acute and chronic musculoskeletal manifestations. 

 

Eight thousand participants are monitored by a 3-year prospective cohort in order to estimate the rate of severity and chronification, as well as other factors associated with the disease.

 

This project evaluates disease management strategies in addition to estimating the socioeconomic and psychosocial impacts of Chikungunya, in order to provide evidence to guide health care strategies and policies across Brazil.

Resposta

Terapêutica

RESEARCH AREAS

Clinical

Research

Therapeutic

Response

Severity &
Warning Signs

 

Compli-

mentary

Therapies

Bioresouce

Management

Drug

Therapy

Comm. &

Community

Engagement

Epidemiology

Survaillance

Translational

Epidemiology

Translational

Research

 

REPLICK

Replick is an interinstitutional clinical research partnership applied to Chikungunya, which aims to establish a biorepository/biobank on the disease.

The study is funded by the Department of Science and Technology (Decit) of the Brazilian Ministry of  Health, and counts with 11 research centers in nine Brazilian states. Replick is coordinated by the Evandro Chagas National Institute of Infectious Diseases (INI/Fiocruz), in Rio de Janeiro.​

 

Sign up for updates!

© 2020 Rede de Pesquisa Clínica e Aplicada em Chikungunya (Replick)